Galderma gets CRL for anti-wrinkle drug; Kimball buys CDMO for $103M

July 2, 2026 09:43 AM EDT Manufacturing Gal­der­ma gets CRL for an­ti-wrin­kle drug; Kim­ball buys CD­MO for $103M Anna Brown News Reporter Plus more from Lon­za, Icosagen and oth­ers. 🟥 Gal­der­ma’s CRL: Gal­der­ma has re­ceived a com­plete re­sponse let­ter from the FDA for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER